Nemaura Medical Inc. announced that Dewan Fazlul Hoque Chowdhury, Chief Executive Officer, President, member of the Board of Directors and significant stockholder of the Company, will act as principal financial officer and principal accounting officer of the Company. Dr. Chowdhury, age 49, has been the Company's President, Chief Executive Officer and a member of the Company's board of directors since the incorporation of Dermal Diagnostics Limited (DDL"), an indirect wholly owned subsidiary of the Company, on January 20, 2009. He is in charge of research and development of the Company's core technologies, product development, innovation and commercialization.

He also coordinates and oversees legal compliance; development of the Company's mission; and policy and planning. Prior to establishing the Company, Dr. Chowdhury was the founder and CEO of Microneedle Technologies and Nemaura Pharma Limited. Dr. Chowdhury has been responsible for negotiating commercial deals for pharmaceuticals and diagnostic devices.

Additionally, he is involved in commercial negotiations and global strategy development. Dr. Chowdhury originally trained as a pharmaceutical scientist and has an MSc in Microsystems and Nanotechnology and med-tech from Cranfield University, and a Doctorate from the University of Oxford on nano-drug delivery. His experience in the pharmaceutical and med-tech industry includes product development; manufacturing; and technical and corporate management.